Earnings · China A-shares
InnoCare Pharma Ltd. Class A (688428) earnings
InnoCare Pharma Ltd. Class A published its Q3 report on 2026-10-26: net profit +1117.93% year on year, +532.98% excluding one-off items. Wave Radar's earnings-quality score is 82 of 100 (Sound). The stock moved -4.08% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-26
- Period end
- 2026-09-30
- Net profit YoY
- +1117.93%
- Excl. one-offs YoY
- +532.98%
- Net profit QoQ
- +191.27%
- Result
- Great
- Quality score
- 82
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -2.25% | — |
| 3 days | -4.08% | — |
| 7 days | +1.20% | — |
| 14 days | -2.91% | — |
Report history
Over the last 8 reports, net profit grew year on year in 8 of them. The stock rose in the 3 trading days after 4 of 8 reports (average +1.37%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-27 | ¥655.70M | +1117.93% | +532.98% | +88.21% | 0.39 | 8.25% | -4.08% | — | — |
| 2026 interim report | 2026-08-25 | ¥246.36M | +918.69% | +327.38% | +55.46% | 0.14 | 3.20% | +4.87% | -4.25% | +1.78% |
| 2026 Q1 report | 2026-04-24 | ¥105.82M | +488.93% | +5927.02% | +38.65% | 0.06 | 1.40% | -4.40% | -26.89% | -27.30% |
| 2025 annual report | 2026-03-26 | ¥642.47M | +245.81% | +225.71% | +135.27% | 0.38 | 9.02% | +11.44% | +9.05% | -0.12% |
| 2025 Q3 report | 2025-11-14 | -¥64.41M | +76.61% | +49.32% | +59.85% | -0.04 | -0.96% | -2.70% | -13.79% | -11.29% |
| 2025 interim report | 2025-08-20 | -¥30.09M | +88.51% | +67.43% | +74.26% | -0.02 | -0.45% | -4.53% | -10.34% | -20.39% |
| 2025 Q1 report | 2025-05-14 | ¥17.97M | +112.62% | +101.19% | +129.92% | 0.01 | 0.27% | +2.75% | +17.54% | +15.16% |
| 2024 annual report | 2025-03-28 | -¥440.63M | +30.20% | +29.66% | +36.68% | -0.26 | -6.36% | +7.58% | +11.73% | +12.82% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.